CryoLife to Participate in 20th Annual Needham Virtual Healthcare Conference
Get Alerts CRY Hot Sheet
Join SI Premium – FREE
ATLANTA, April 7, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 20th Annual Needham Virtual Healthcare Conference on Wednesday, April 14, 2021. The Company's virtual fireside chat is scheduled to begin at 8:45 a.m. ET.
A live webcast of the virtual fireside chat will be accessible through CryoLife's website, www.cryolife.com, on the Investor Relations page. An archived copy of the webcast will be available for 90 days on the same website.
About CryoLife, Inc. Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide. For additional information about CryoLife, visit our website, www.cryolife.com.
Contacts:
CryoLife | Gilmartin Group LLC |
D. Ashley Lee | Brian Johnston / Lynn Lewis |
Executive Vice President, Chief Financial Officer and Chief Operating Officer | Phone: 631-807-1986 |
Phone: 770-419-3355 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/cryolife-to-participate-in-20th-annual-needham-virtual-healthcare-conference-301263812.html
SOURCE CryoLife, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Everpure Named A Leader in the 2026 Gartner® Magic Quadrant™ for Enterprise Storage Platforms
- Ceretone and Easter Seals Greater Houston Bring Hearing Technology to Local Seniors Through Community Initiative
- Intero Real Estate Professionals Named in 2026 Leading 100 List
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share